We therefore used siRNA to knockdown expression of NFKB1 (p50) and ETS1 by approximately 75% or greater in non-stimulated and IL-36-treated KCs (Figure S13 in Supplementary Material). This evidence concerns the gene ETS1 and dry eye syndrome.